Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval
pharmaphorum
MAY 16, 2022
Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to help keep their glucose levels in check. The drug is injected under the skin once a week and the dose can be adjusted to meet an individual’s blood sugar needs. more than insulin degludec and 1.0%
Let's personalize your content